Switzerland· 51884132

Physiotens forte 0,4 mg, Filmtabletten

A moxonidine product containing moxonidinum, registered in Switzerland by Viatris Pharma GmbH and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC C02AC05

Checked against Swissmedic (Switzerland) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about moxonidinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Moxonidine is registered in 13 of 19 countries.

Countries holding a registration under ATC C02AC05 (moxonidine), each read from that country’s own register.

This record: Switzerland, from Swissmedic (Switzerland)
8 of them publish a price we can compare per daily dose

Search moxonidine products by name

Moxonidine · ATC C02AC05

13 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of moxonidine costs, country by country.

Normalised to the WHO defined daily dose (0.3 mg), the median price runs from $0.19 in France to $0.70 in Switzerland — a ×3.7 gap.

Switzerland: $0.70 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Moxonidine · price per daily dose (0.3 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.70
IT Italy$0.35
FR France$0.19

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)

Active substance: moxonidinum
Manufacturer: Viatris Pharma GmbH
Country: Switzerland (CH)
ATC code: C02AC05
ATC class: Moxonidine
Defined daily dose: 0.3 mg, O
Swissmedic category: B
Reimbursed: Yes
Source register: Swissmedic (Switzerland)
Last checked: September 12, 2026

Packs & prices · 1

1 priced

gtin
7680518841321
98 Stk
CHF 47.35

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Moxonidine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All moxonidine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Moxonibene, Moxonidin Stada
Belgium · Moxonidine Eg, Moxonidine Sandoz
Bulgaria · Moxotens, Moксотенс
Cyprus · Physiotens, Tarwoxin
Czechia · Cynt, Moxonidin Actavis
Germany · Moxogamma, Moxonidin 1 A Pharma
Denmark · Moxonat, Moxonidin Teva
Estonia · Moxogamma, Moxonidin Actavis
Spain · Moxon
Finland · Moxonidin Ratiopharm, Moxonidin Stada
France · Moxonidine Biogaran, Moxonidine Eg
United Kingdom (Northern Ireland) · Moxonidine, Moxonidine Generics [uk]
Greece · Cynt, Fisiotens
Croatia · Cynt, Moksonidin Belupo
Hungary · Moxogamma, Moxonidin Ratiopharm
Italy · Fisiotens, Moxonidina Eg
Lithuania · Moxogamma, Moxonidin Hexal
Luxembourg · Moxonidine Eg, Moxonidine Viatris
Latvia · Moxogamma, Moxonidin Actavis
Malta · Physiotens
Netherlands · Moxamar, Moxonidine Pch
Norway · Moxonidin Actavis, Physiotens
Poland · Physiotens
Portugal · Moxon
Romania · Physiotens
Sweden · Moxonidin Actavis, Moxonidin Stada
Slovenia · Filmsko Obložene Tablete, Moxogamma, Moxogamma
Slovakia · Moxogamma, Moxonidin Ratiopharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/013c8cf1-d7b6-478d-b356-9e2cbe425b2b
GET /v1/drugs/013c8cf1-d7b6-478d-b356-9e2cbe425b2b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "moxonidinum 0.4 mg",
  "valid_from": "1994-03-15",
  "limitations": "[{\"description\":\"Vergütung nur bei Patienten mit essentieller Hypertonie, die bereits mit diesem Medikament eingestellt sind sowie bei Patienten, die auf andere Therapien gegen Hypertonie (wie etwa Betablockern und/oder Kalziumantagonisten und/oder ACE-Hemmern und/oder Angiotensin-II-Rezeptor-Antagonisten und/oder Diuretika und/oder Kombinationstherapien derselben) nur ungenügend ansprechen oder wenn diese Therapien kontraindiziert oder unverträglich sind.\\n\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2022-01-01\"}]",
  "galenic_form": "Tabl 0.4 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "1994-03-15",
  "self_retention_pct": 10
}

API reference MCP server Plans

See everything about moxonidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console